Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

 

CVD-REAL - Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors.

Interview with Professor Mikhail Kosiborod from University of Missouri - Kansas City, Missouri, USA at ACC 2017